Andere talen Lee's Pharmaceutical Holdings Limited

Aandelen

950 KYG5438W1116

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:09:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,18 ^HKD	+2,61%		+9,26%	-22,88%

19/04	Winst Lee's Pharmaceutical daalt in 2023 met 67%	MT
26/03	Lee's Pharmaceutical Holdings Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Lee’s Pharmaceutical's 2023 Profit Slumps 67%	19/04
Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024	26/03
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
China Grants Lee's Pharmaceutical Drug Registration for Schizophrenia-Related Agitation Treatment; Shares Rise 3%	29/11
Lee’s Pharmaceutical Sells Rights for Eyprotor to Zhaoke Ophthalmology for 60 Million Yuan	14/11
Lee's Pharmaceutical Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 October 2023	30-08-23
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30-08-23
Lee's Pharmaceutical Holdings Unit's Fentanyl Inhalable Reaches Endpoints in Phase 2A Trial	22-08-23
Lee's Pharmaceutical Holdings Limited Announces Phase IIa Clinical Trial of A F fentanyl Aerosol for Inhalation Conducted by Zhaoke Pharmaceutical Limited	21-08-23
Lee's Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023	21-08-23
Lee’s Pharmaceutical Gets Registration Certificate for Medical Device to Treat Hypoxic Respiratory Failure	09-06-23
Lee's Pharmaceutical Holdings Limited Appoints Cheang Yee Wah, Eva as Independent Non-Executive Director	17-05-23
Lee's Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 15 June 2023	30-03-23
Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30-03-23
Lee’s Pharmaceutical Holdings Warns of Plunge in 2022 Profit	21-03-23
Lee's Pharmaceutical Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	20-03-23
Extended Phase 2b Study for Lee's Pharmaceutical's Tafoxiparin Concludes; Shares Slip 3%	17-02-23
Nine Lee's Pharma Products Included in China's National Reimbursement Drug List	20-01-23
Lee's Pharmaceutical Holdings Limited Announces Inclusion of Treprostinil Injection, Teglutik and Trittico in the National Reimbursement Drug List	19-01-23
Lee's Pharmaceutical's Q3 Profit More Than Doubles	24-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Lee's Pharmaceutical Holdings Limited

Aandelen

950

KYG5438W1116

Andere talen

Filters